Patents by Inventor Franz Xaver Heinz

Franz Xaver Heinz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Attenuated live vaccines
    Patent number: 8784839
    Abstract: Disclosed is an attenuated flavivirus live vaccine comprising a flavivirus mutant, characterized in that the flavivirus mutant has a deletion in the capsid protein of at least more than 4 successive amino acids, wherein the carboxy-terminal hydrophobic region is not affected by the deletion.
    Type: Grant
    Filed: March 15, 2011
    Date of Patent: July 22, 2014
    Assignee: Valneva Austria GmbH
    Inventors: Franz Xaver Heinz, Christian Mandl
  • Attenuated live vaccine
    Patent number: 8486419
    Abstract: Disclosed is an attenuated flavivirus live vaccine comprising a flavivirus mutant, characterized in that the flavivirus mutant has a deletion in the capsid protein of at least more than 4 successive amino acids, wherein the carboxy-terminal hydrophobic region is not affected by the deletion.
    Type: Grant
    Filed: February 11, 2002
    Date of Patent: July 16, 2013
    Assignee: Intercell AG
    Inventors: Franz Xaver Heinz, Christian Mandl
  • ATTENUATED LIVE VACCINES
    Publication number: 20110165230
    Abstract: Disclosed is an attenuated flavivirus live vaccine comprising a flavivirus mutant, characterised in that the flavivirus mutant has a deletion in the capsid protein of at least more than 4 successive amino acids, wherein the carboxy-terminal hydrophobic region is not affected by the deletion.
    Type: Application
    Filed: March 15, 2011
    Publication date: July 7, 2011
    Inventors: Franz Xaver HEINZ, Christian MANDL
  • Attenuated live vaccine
    Publication number: 20040052818
    Abstract: Disclosed is an attenuated flavivirus live vaccine comprising a flavivirus mutant, characterised in that the flavivirus mutant has a deletion in the capsid protein of at least more than 4 successive amino acids, wherein the carboxy-terminal hydrophobic region is not affected by the deletion.
    Type: Application
    Filed: October 23, 2003
    Publication date: March 18, 2004
    Inventors: Franz Xaver Heinz, Christian Mandl